Christine S Rollier

10PUBLICATIONS
68CO-AUTHORS
Animal protection (incl. pests and pathogens)Medical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteinsInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 30, 2026
Pathogen-specific immune responses might underlie divergent outcomes of coronavirus and influenza infection in the natural porcine host.

|May 07, 2025
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.

Christina Dold, Blanché Oguti, Laura Silva-Reyes

|Jun 21, 2023
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.

Christina Dold, Leanne Marsay, Nelson Wang

|Jan 26, 2022
Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.

Christine S Rollier, Christina Dold, Leanne Marsay

|May 07, 2021
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold

|Jan 29, 2021
MAIT cell activation augments adenovirus vector vaccine immunogenicity.

Nicholas M Provine, Ali Amini, Lucy C Garner

Pageof 2

Frequent Collaborators

6 joint publications

Andrew J Pollard

4 joint publications

Adrian V S Hill

3 joint publications

Teresa Lambe

2 joint publications

Daniel Jenkin